New insights into digestive tract tumors  

作　　者：Zhidong Gao Zhanlong Shen Shuo Wang Yingjiang Ye 

机构地区：[1]Department of Gastroenterological Surgery,Peking University People's Hospital,Beijing 100044,China [2]Laboratory of Surgical Oncology,Peking University People's Hospital,Beijing 100044,China

出　　处：《Cancer Pathogenesis and Therapy》2024年第4期217-218,共2页癌症发生与治疗（英文）

基　　金：the Beijing Xisike Clinical Oncology Research Foundation(No.Y-xsk2021-0004).

摘　　要：Digestive tract tumors,ranging from esophageal to colorectal cancers(CRCs),pose a substantial challenge in oncology because of their high global incidence and mortality.1,2 The heterogeneity of these malignancies underscores the complexity of their etiology,which is influenced by a combination of genetic,epigenetic,and environmental factors.3 Unraveling the molecular complexities and clinical implications of these tumors is of growing importance,as they provide insights that can inform the development of more effective diagnostic,therapeutic,and preventative approaches.The Special Issue,titled“Basic research and clinical practice on gastrointestinal cancer”,aims to highlight the recent advances in molecular mechanisms and clinical research in the field of digestive tract oncology.We hope that by presenting these findings we can foster collaboration and dialog among experts in the field,ultimately leading to innovative perspectives on the diagnosis and treatment of these cancers.

关 键 词：Digestive tract tumors TGF-Β SDC2 IMMUNOTHERAPY SNHG8 

分 类 号：R735[医药卫生—肿瘤]